MyFinsight
Home
Blog
About
Cash and cash
equivalents
$46,288K
(74.74%↑ Y/Y)
Accounts receivable (net
of allowance of 98...
$6,459K
(15.94%↑ Y/Y)
Inventory, net
$4,205K
(10.45%↑ Y/Y)
Prepaid expenses
$2,792K
(25.99%↑ Y/Y)
Total current assets
$59,744K
(56.87%↑ Y/Y)
Property and equipment,
net
$1,837K
(7.36%↑ Y/Y)
Right-of-use assets
$798K
(-27.65%↓ Y/Y)
Other assets
$69K
(-83.53%↓ Y/Y)
Total assets
$62,448K
(51.14%↑ Y/Y)
Total liabilities and
stockholders equity...
$62,448K
(51.14%↑ Y/Y)
Total liabilities
$55,898K
(-7.97%↓ Y/Y)
Total stockholders
equity (deficit)
$6,550K
(133.72%↑ Y/Y)
Accumulated deficit
-$338,231K
(-13.42%↓ Y/Y)
Long-term debt
$33,065K
(2.45%↑ Y/Y)
Total current
liabilities
$11,172K
(19.82%↑ Y/Y)
Warrant liabilities
$6,317K
(-36.81%↓ Y/Y)
Contingent earnout
liability
$3,738K
(-50.31%↓ Y/Y)
Long-term lease
liabilities
$1,117K
(-11.70%↓ Y/Y)
Revenue base redemption
liability
$489K
(36.59%↑ Y/Y)
Additional paid-in capital
$344,776K
(23.67%↑ Y/Y)
Common stock, 0.0001
par value,...
$5K
(66.67%↑ Y/Y)
Accrued liabilities
$7,107K
(0.41%↑ Y/Y)
Trade payables
$3,763K
(97.84%↑ Y/Y)
Short-term lease
liabilities
$244K
(98.37%↑ Y/Y)
Other current
liabilities
$58K
(-73.76%↓ Y/Y)
Back
Back
Balance Sheet
TriSalus Life Sciences, Inc. (TLSIW)
TriSalus Life Sciences, Inc. (TLSIW)
source: myfinsight.com